miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Oncotarget
; 7(43): 70699-70714, 2016 Oct 25.
Article
in En
| MEDLINE
| ID: mdl-27683111
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organoplatinum Compounds
/
Stomach Neoplasms
/
Gene Expression Regulation, Neoplastic
/
Drug Resistance, Neoplasm
/
MicroRNAs
/
E2F1 Transcription Factor
/
Neoplasm Recurrence, Local
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Oncotarget
Year:
2016
Document type:
Article
Affiliation country:
China